Andel

Andel is a healthcare technology platform launched in early 2026 that provides affordable access to high-cost, FDA-approved medications, with an initial focus on GLP-1 therapies for obesity management. The company operates a unique cooperative model that aggregates the purchasing power of its network to source medications directly from pharmaceutical manufacturers, bypassing traditional insurance limitations and high retail markups. Its digital platform enables employers and plan sponsors to offer these medications as a transparent, predictable employee benefit. By streamlining the supply chain and removing administrative friction, Andel aims to make life-changing treatments accessible to millions of patients who fall outside traditional coverage criteria.